Parkinson’s disease: Servier, a committed stakeholder
Committed to neuroscience, Servier is focusing its research efforts on the discovery of drug candidates that slow the progression of Parkinson’s disease, as well as clinically-related diseases. Discover the Group’s commitment in video.
